BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9987445)

  • 1. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the AutoPap primary screening system at Jefferson University Hospital.
    Bibbo M; Hawthorne C
    Acta Cytol; 1999; 43(1):27-9. PubMed ID: 9987446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
    Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
    Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations.
    Bishop JW; Kaufman RH; Taylor DA
    Acta Cytol; 1999; 43(1):34-8. PubMed ID: 9987448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
    Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AutoCyte Interactive Screening System. Experience at a university hospital cytology laboratory.
    Howell LP; Belk T; Agdigos R; Davis R; Lowe J
    Acta Cytol; 1999; 43(1):58-64. PubMed ID: 9987451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of automated primary screening on liquid-based, thin-layer preparations.
    Vassilakos P; Carrel S; Petignat P; Boulvain M; Campana A
    Acta Cytol; 2002; 46(2):291-5. PubMed ID: 11917575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
    Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
    Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
    Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assisted primary screening using the automated ThinPrep Imaging System.
    Biscotti CV; Dawson AE; Dziura B; Galup L; Darragh T; Rahemtulla A; Wills-Frank L
    Am J Clin Pathol; 2005 Feb; 123(2):281-7. PubMed ID: 15842055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories.
    Vassilakos P; Saurel J; Rondez R
    Acta Cytol; 1999; 43(1):65-8. PubMed ID: 9987452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
    Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
    Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.